Computer Based Systems

(OMCL) Omnicell Pinned at Neutral

Following a strong third-quarter result, we have reiterated our long-term ‘Neutral’ recommendation on Omnicell (OMCL), provider of end-to-end automation solutions for the medication-use process, with a target price of $16.00.

In...

2Jan2013 | | Comments Off on (OMCL) Omnicell Pinned at Neutral | Continued

(OMCL) Omnicell Analyst Reaffirms Shares at Neutral

We recently reiterated our Neutral recommendation on Omnicell (OMCL) with a target price of $17.00.

Omnicell reported adjusted EPS of 9 cents in the third quarter of fiscal 2011, beating the Zacks Consensus Estimate by a penny...

14Dec2011 | | 0 comments | Continued

(OMCL) Omnicell’s G4 Platform Reaches China

Recently, Omnicell (OMCL) announced the launch of Mandarin-language versions of its G4 platform for clinical use in China. Following the launch of G4 medication automation platform in English-speaking markets earlier this year, the...

30Nov2011 | | 0 comments | Continued

(OMCL) Omnicell Beats Estimates

Omnicell Inc. (OMCL) reported EPS of 9 cents during the second quarter of fiscal 2011, beating both the Zacks Consensus Estimate of 8 cents and the year-ago quarter EPS of 4 cents. Reported earnings shot up 125% on a year-over-year...

4Nov2011 | | 0 comments | Continued

(OMCL) Omnicell Analyst Maintains Neutral on Shares

We recently reiterated our Neutral recommendation on Omnicell (OMCL) with a target price of $16.00.

Omnicell reported an adjusted EPS of 8 cents in the second quarter of fiscal 2011, beating both the Zacks Consensus Estimate...

20Sep2011 | | 0 comments | Continued

(OMCL) Omnicell’s Electronic Health Record Wins Certification

Omnicell, Inc. (OMCL), a leading developer and marketer of end-to-end automation solutions for the medication-use process, recently announced that its newly launched G4 platform received the ONC-ATCB certification as a Modular Electronic...

22Jun2011 | | 0 comments | Continued

(OMCL) Omnicell Earns Second Consecutive Best in Klas Award

Omnicell (OMCL), recently announced that it has received recognition for its OmniRx automated dispensing system from leading research firm, KLAS for the second consecutive year.  Along with the  2011 “Best in KLAS” award...

19Jun2011 | | 0 comments | Continued

(EU) International Business Machine Faces Anti-trust Probes

The European Union (EU) has accused International Business Machine Corp. (IBM) of violating anti-trust guidelines and misusing its dominant position in the Mainframe computer market. The European Commission, the executive arm of European...

27Jul2010 | | 0 comments | Continued

(OMCL) Omnicell Incorporated – Bull of the Day

Hospital services like those provided by Omnicell, Inc. (OMCL) should exhibit strong growth over the long-term, benefiting from favorable demographic trends, regulatory environments and a lack of nursing staff. The market also remains...

18Apr2010 | | 0 comments | Continued

(OMCL) Omnicell Analyst Upgrades Shares

We recently upgraded Omnicell, Inc. (OMCL) to an ‘Outperform’ with a target price of $15.50 based on a P/S of 2.2x our fiscal 2010 revenue estimate of $225 million. The company’s strong long-term outlook prompts us to upgrade...

9Apr2010 | | 0 comments | Continued

(OMCL) Omnicell Analysts Maintain Neutral Rating

We recently reiterated our Neutral rating on Omnicell, Inc. (OMCL) with a target price of $15.50.

Omnicell reported disappointing results in the fourth quarter and fiscal 2009. In the fourth quarter, earnings per share were...

10Mar2010 | | 0 comments | Continued

(OMCL) Omnicell Enters New Contract With Carolinas HealthCare System

Omnicell, Inc. (OMCL) recently entered into a new contract with Carolinas HealthCare System (CHS) whereby the latter has selected Omnicell’s OmniRx automated medication dispensing cabinets (ADCs) to streamline management of medications...

7Dec2009 | | 0 comments | Continued

(OMCL) Omnicell Launches New Product

Omnicell, Inc. (OMCL) recently launched a new product, Omnicell 14.0 with Anywhere RN, a software solution used in conjunction with Omnicell’s automated medication dispensing cabinets to ensure safe, efficient and accessible...

25Nov2009 | | 0 comments | Continued

(OMCL) Omnicell Eclipses Consensus Estimate

Omnicell Inc. (OMCL) reported third quarter 2009 earnings per share of 10 cents yesterday, beating the Zacks Consensus Estimate of 2 cents. However, earnings per share came below the year-ago figure of 18 cents.

Total revenues...

26Oct2009 | | 0 comments | Continued